Premium
Latex allergy risk assessment in children and adolescents with type I diabetes mellitus
Author(s) -
Bostancý I.,
Dallar Y.,
Ünsal Sac R.,
Karakoc E.,
Doganay B.
Publication year - 2007
Publication title -
pediatric allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 89
eISSN - 1399-3038
pISSN - 0905-6157
DOI - 10.1111/j.1399-3038.2007.00585.x
Subject(s) - medicine , type 1 diabetes , diabetes mellitus , allergy , latex allergy , risk assessment , type 2 diabetes mellitus , pediatrics , immunology , endocrinology , computer security , computer science
An increased frequency of allergic reactions to latex has been reported in specific populations with chronic latex exposure. However, relevance of latex allergy to children and adolescents with type I diabetes mellitus (DM1) has not been studied yet. The aim of the studty is to assess latex allergy risk in children and adolescents with DM1. Thirty‐nine children with DM1 and 35 controls were enrolled. In a case‐control study, we applied to all subjects a standard questionnaire, and specific Immunoglobulin E (IgE) concentrations for latex, common aeroallergens, and food‐allergens were measured in serum samples. Latex exposure rates by means of medical procedures, operations, and latex glove usage were not different between DM1 and controls. Symptoms due to latex exposure were not determined in both groups. Three (7.7%) subjects in DM1 tested positive for latex‐specific antibodies (LSIE), whereas no subject in controls. Diabetics that tested positive for latex‐specific antibodies had the disease for three, 5 and 8 years. Nine (23.1%) of diabetics, and two (5.7%) of controls were atopic (p = 0.04). In our investigation, we found that children and adolescents with DM1 are not a risk group for latex allergy, and LSIE in children with DM1 was not accompanied by symptoms of latex allergy, or, presumably, increased risk of latex anaphylaxis.